Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 09:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
Latest news
Date Title
<1m agoDJFiji Attracts Old Friends as China's Clout Grows
1m ago UNITED SECURITY BANCSHARES : 2014 Q3 USBI Press Release (10/29/14)
1m ago PODRAVKA : Notice on Sessions of the Management and the Supervisory Board of Podravka Inc.
1m ago MARRIOTT : Wins CHTA Innovation Award 2014 for Mobility Leadership
1m ago SPIRIT PUB : Form 8.3 - Spirit Pub Co plc
1m ago DTS8 COFFEE : Other Events (form 8-K)
1m ago MASTERCARD : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
1m agoDJVodafone Says Hungary Should Revoke Plan to Tax Internet Use --Update
1m ago OILDEX : a Service of Transzap, Inc. Named to Software Magazine’s 32nd Annual Software 500
2m ago Celebs Say ‘Bore Off!’ – Now You Can Too!
Latest news
Advertisement
Hot News 
CERAGON NETWORKS : Reports Third Quarter 2014 Financial Results
NISKA GAS STORAGE PARTNERS : Announces Second Quarter Results for Fiscal 2015, Declares Quarterly Distribution and Provides Update on Current Business Environment and Outlook
ACCURAY : misses Street 1Q forecasts
ABIOMED : Announces Second Quarter Fiscal 2015 Revenue of $51.9 Million, Up 17% Over Prior Year
WESTERN GAS PARTNERS : Prices Public Offering of 7,500,000 Common Units
Most Read News
1h ago WORLD WRESTLING ENTERTAINMENT : WWE :® Reports 2014 Third Quarter Results
1d ago MEDASSETS : tops Street 3Q forecasts
1d ago GENERAL MOTORS' : Trademark Application for "GOODWRENCH" Filed
5h ago Volkswagen profit jumps on record Audi, Porsche sales
2h ago Lufthansa shares drop after 2015 profit guidance cut for second time
Most recommended articles
1m agoDJVODAFONE : Says Hungary Should Revoke Plan to Tax Internet Use --Update
2m agoDJEuropean Bank Stocks Slip
2m ago Daimler, VW dampen speculation about imminent CEO succession
4m ago Goldcorp results lag expectations, stock drops
10m agoDJCME Group Profit Rises 23% as Trading Volume Grows
Dynamic quotes  
ON
| OFF